Central fatigue during exercise: potential manuipulations and limiting factors

The development of fatigue has been an area of interest to athletes and scientists alike for many years. Often, particularly during prolonged exercise in the heat, there is no obvious peripheral reason for fatigue and the central nervous system is cited as the source. The mechanisms and potential manipulations of this fatigue remain largely unclear. Chapters Three and Four attempted to reduce the transport of the serotonin precursor tryptophan into the brain in order to reduce or delay serotonin synthesis and therefore increase exercise capacity. In Chapter Three branched-chain amino acid drinks were fed before and during prolonged cycling to exhaustion in the heat on two occasions and control drinks were fed on two other occasions. There was no effect of the branched-chain amino acids on exercise capacity and the intra-individual variability in seven of the eight participants was small. One participant did appear to cycle for longer on the branched-chain amino acid trials compared to the control trials. In Chapter Four a 104 g bolus of amino acids, designed to deplete plasma tryptophan concentration, was fed seven hours before a prolonged cycle to exhaustion in the heat. There was no difference in exercise capacity between the tryptophan depletion trial and the control trial in which tryptophan was also ingested. These findings suggest that the delivery of tryptophan to the central nervous system is not the only factor influencing the onset of fatigue. The investigation undertaken in Chapter Five looked at the serotonin transporter density on the blood platelets of current and retired international level athletes competing in either endurance or sprint running events and a sedentary control group. Using the platelet as an accessible and reliable model for the serotonergic neuron, the maximum number of binding sites was assessed using the radio-labelled serotonin reuptake inhibitor [3H]Paroxetine. Those currently training for endurance events had a greater number of binding sites than any of the other groups. This supports previous findings and suggests that endurance training can increase the number of serotonin transporters on blood platelet membranes. During resting heat exposure in Chapter Six, the application of a 1 % menthol solution to the skin of the forearms, back and forehead elicited a warming sensation in some individuals and a cooling sensation in other individuals, but never any change in skin or core temperature nor skin blood flow. A small proportion of individuals did not perceive any change in skin thermal sensation. Chapter Seven applied these findings to a pre-loaded twenty minute exercise performance test in the heat. It was hypothesised that those who perceived a warming effect may perform worse when a menthol solution was applied compared to a control solution and conversely, those who perceived a cooling sensation may perform better with a menthol solution than with a control solution. There was no difference in exercise performance between those who felt a warming sensation and those who felt a cooling sensation. Those who felt a warming sensation felt significantly warmer on the menthol trial than the control trial but this did not affect their performance. However, those who reported a cooling sensation tended to feel cooler on the menthol trial than the control trial, and there was a tendency for an improvement in performance on the menthol trial compared to the control trial. Due to the experimental protocols adopted in this thesis it was possible to assess the reliability of an exercise capacity test compared to an exercise performance test. Chapter Three showed a coefficient of variation of 11.0 ± 11.2 % and Chapter Four showed a 11.5 ± 12.4 % variability for exercise capacity tests. Chapter Seven showed a coefficient of variation in a pre-loaded time-trial exercise performance test of 3.9 ± 9.6 % suggesting that an exercise performance test may be more reliable than an exercise capacity test. However, the aims of an investigation are still likely to be the main factor influencing the choice of protocol. It seems likely that no single mechanism will be responsible for the cessation of exercise. The investigations undertaken in this thesis also highlight many avenues for future exploration

Central fatigue during exercise : potential manipulations and limiting factors

The development of fatigue has been an area of interest to athletes and scientists alike for many years. Often, particularly during prolonged exercise in the heat, there is no obvious peripheral reason for fatigue and the central nervous system is cited as the source. The mechanisms and potential manipulations of this fatigue remain largely unclear. Chapters Three and Four attempted to reduce the transport of the serotonin precursor tryptophan into the brain in order to reduce or delay serotonin synthesis and therefore increase exercise capacity. In Chapter Three branched-chain amino acid drinks were fed before and during prolonged cycling to exhaustion in the heat on two occasions and control drinks were fed on two other occasions. There was no effect of the branched-chain amino acids on exercise capacity and the intra-individual variability in seven of the eight participants was small. One participant did appear to cycle for longer on the branched-chain amino acid trials compared to the control trials. In Chapter Four a 104 g bolus of amino acids, designed to deplete plasma tryptophan concentration, was fed seven hours before a prolonged cycle to exhaustion in the heat. There was no difference in exercise capacity between the tryptophan depletion trial and the control trial in which tryptophan was also ingested. These findings suggest that the delivery of tryptophan to the central nervous system is not the only factor influencing the onset of fatigue. The investigation undertaken in Chapter Five looked at the serotonin transporter density on the blood platelets of current and retired international level athletes competing in either endurance or sprint running events and a sedentary control group. Using the platelet as an accessible and reliable model for the serotonergic neuron, the maximum number of binding sites was assessed using the radio-labelled serotonin reuptake inhibitor [3H]Paroxetine. Those currently training for endurance events had a greater number of binding sites than any of the other groups. This supports previous findings and suggests that endurance training can increase the number of serotonin transporters on blood platelet membranes. During resting heat exposure in Chapter Six, the application of a 1 % menthol solution to the skin of the forearms, back and forehead elicited a warming sensation in some individuals and a cooling sensation in other individuals, but never any change in skin or core temperature nor skin blood flow. A small proportion of individuals did not perceive any change in skin thermal sensation. Chapter Seven applied these findings to a pre-loaded twenty minute exercise performance test in the heat. It was hypothesised that those who perceived a warming effect may perform worse when a menthol solution was applied compared to a control solution and conversely, those who perceived a cooling sensation may perform better with a menthol solution than with a control solution. There was no difference in exercise performance between those who felt a warming sensation and those who felt a cooling sensation. Those who felt a warming sensation felt significantly warmer on the menthol trial than the control trial but this did not affect their performance. However, those who reported a cooling sensation tended to feel cooler on the menthol trial than the control trial, and there was a tendency for an improvement in performance on the menthol trial compared to the control trial. Due to the experimental protocols adopted in this thesis it was possible to assess the reliability of an exercise capacity test compared to an exercise performance test. Chapter Three showed a coefficient of variation of 11.0 ± 11.2 % and Chapter Four showed a 11.5 ± 12.4 % variability for exercise capacity tests. Chapter Seven showed a coefficient of variation in a pre-loaded time-trial exercise performance test of 3.9 ± 9.6 % suggesting that an exercise performance test may be more reliable than an exercise capacity test. However, the aims of an investigation are still likely to be the main factor influencing the choice of protocol. It seems likely that no single mechanism will be responsible for the cessation of exercise. The investigations undertaken in this thesis also highlight many avenues for future exploration.EThOS - Electronic Theses Online ServiceGBUnited Kingdo

Experiential aspects of tourism gift consumption

This article addresses how consumers make use of fantasy, feelings, and fun when deciding, giving, and consuming gifts of tourism and leisure. Despite little industry awareness, consumers are engaging with such behaviour because tourism gifts offer considerable scope for the creative expression of donor–recipient relationships. This UK-based interpretive qualitative study captured data from donors, recipients, and tourism and leisure providers. The feelings (emotions), fantasies (imagination and dreaming), and fun (playfulness) were interrogated through the behavioural phases of gift decision making, gift exchange, post-exchange, and gift consumption. A range of emotions were displayed by donors and recipients at different stages in the gift-giving process; donor decision making in groups for created gifts was particularly charged. Fantasies were evident both for donors planning gifts and for recipients. As an intangible gift, means of exchange allowed for creative mechanisms beyond the classic wrapping strategies associated with physical gifts. The ‘decoy’ strategy stimulated the recipient’s imagination to conjure fantastical scenarios. Fun or playfulness was built into many of the gifts and often related to an element of ‘surprise’, an attribute of the perfect gift (e.g. Belk, 1996) in Western societies

Effects of beta-alanine supplementation on brain homocarnosine/carnosine signal and cognitive function: an exploratory study

Objectives: Two independent studies were conducted to examine the effects of 28 d of beta-alanine supplementation at 6.4 g d-1 on brain homocarnosine/carnosine signal in omnivores and vegetarians (Study 1) and on cognitive function before and after exercise in trained cyclists (Study 2). Methods: In Study 1, seven healthy vegetarians (3 women and 4 men) and seven age- and sex-matched omnivores undertook a brain 1H-MRS exam at baseline and after beta-alanine supplementation. In study 2, nineteen trained male cyclists completed four 20-Km cycling time trials (two pre supplementation and two post supplementation), with a battery of cognitive function tests (Stroop test, Sternberg paradigm, Rapid Visual Information Processing task) being performed before and after exercise on each occasion. Results: In Study 1, there were no within-group effects of beta-alanine supplementation on brain homocarnosine/carnosine signal in either vegetarians (p = 0.99) or omnivores (p = 0.27); nor was there any effect when data from both groups were pooled (p = 0.19). Similarly, there was no group by time interaction for brain homocarnosine/carnosine signal (p = 0.27). In study 2, exercise improved cognitive function across all tests (P0.05) of beta-alanine supplementation on response times or accuracy for the Stroop test, Sternberg paradigm or RVIP task at rest or after exercise. Conclusion: 28 d of beta-alanine supplementation at 6.4g d-1 appeared not to influence brain homocarnosine/ carnosine signal in either omnivores or vegetarians; nor did it influence cognitive function before or after exercise in trained cyclists

Genital herpes evaluation by quantitative TaqMan PCR: correlating single detection and quantity of HSV-2 DNA in cervicovaginal lavage fluids with cross-sectional and longitudinal clinical data

Abstract Objective To evaluate the utility of a single quantitative PCR (qPCR) measurement of HSV (HSV-1&2) DNA in cervicovaginal lavage (CVL) specimens collected from women with predominantly chronic HSV-2 infection in assessing genital HSV shedding and the clinical course of genital herpes (GH) within a cohort with semiannual schedule of follow up and collection of specimens. Methods Two previously described methods used for detection of HSV DNA in mucocutaneous swab samples were adapted for quantification of HSV DNA in CVLs. Single CVL specimens from 509 women were tested. Presence and quantity of CVL HSV DNA were explored in relation to observed cross-sectional and longitudinal clinical data. Results The PCR assay was sensitive and reproducible with a limit of quantification of ~50 copies per milliliter of CVL. Overall, 7% of the samples were positive for HSV-2 DNA with median log10 HSV-2 DNA copy number of 3.9 (IQR: 2.6-5.7). No HSV-1 was detected. Presence and quantity of HSV-2 DNA in CVL directly correlated with the clinical signs and symptoms of presence of active symptomatic disease with frequent recurrences. Conclusion Single qPCR measurement of HSV DNA in CVL fluids of women with chronic HSV-2 infection provided useful information for assessing GH in the setting of infrequent sampling of specimens. Observed positive correlation of the presence and quantity of HSV-2 DNA with the presence of active and more severe course of HSV-2 infection may have clinical significance in the evaluation and management of HSV-2 infected patients

Functional antibody and T-cell immunity following SARS-CoV-2 infection, including by variants of concern, in patients with cancer: the CAPTURE study

Patients with cancer have higher COVID-19 morbidity and mortality. Here we present the prospective CAPTURE study (NCT03226886) integrating longitudinal immune profiling with clinical annotation. Of 357 patients with cancer, 118 were SARS-CoV-2-positive, 94 were symptomatic and 2 patients died of COVID-19. In this cohort, 83% patients had S1-reactive antibodies, 82% had neutralizing antibodies against WT, whereas neutralizing antibody titers (NAbT) against the Alpha, Beta, and Delta variants were substantially reduced. Whereas S1-reactive antibody levels decreased in 13% of patients, NAbT remained stable up to 329 days. Patients also had detectable SARS-CoV-2-specific T cells and CD4+ responses correlating with S1-reactive antibody levels, although patients with hematological malignancies had impaired immune responses that were disease and treatment-specific, but presented compensatory cellular responses, further supported by clinical. Overall, these findings advance the understanding of the nature and duration of immune response to SARS-CoV-2 in patients with cancer

TESS Giants Transiting Giants. I.: A Noninflated Hot Jupiter Orbiting a Massive Subgiant

While the population of confirmed exoplanets continues to grow, the sample of confirmed transiting planets around evolved stars is still limited. We present the discovery and confirmation of a hot Jupiter orbiting TOI-2184 (TIC 176956893), a massive evolved subgiant (M ∗ = 1.53 ± 0.12 M o˙, R ∗ = 2.90 ± 0.14 R o˙) in the Transiting Exoplanet Survey Satellite (TESS) Southern Continuous Viewing Zone. The planet was flagged as a false positive by the TESS Quick-Look Pipeline due to periodic systematics introducing a spurious depth difference between even and odd transits. Using a new pipeline to remove background scattered light in TESS Full Frame Image data, we combine space-based TESS photometry, ground-based photometry, and ground-based radial velocity measurements to report a planet radius of R p = 1.017 ± 0.051 R J and mass of M p = 0.65 ± 0.16 M J . For a planet so close to its star, the mass and radius of TOI-2184b are unusually well matched to those of Jupiter. We find that the radius of TOI-2184b is smaller than theoretically predicted based on its mass and incident flux, providing a valuable new constraint on the timescale of post-main-sequence planet inflation. The discovery of TOI-2184b demonstrates the feasibility of detecting planets around faint (TESS magnitude > 12) post-main-sequence stars and suggests that many more similar systems are waiting to be detected in the TESS FFIs, whose confirmation may elucidate the final stages of planetary system evolution

Prevalence and architecture of de novo mutations in developmental disorders.

The genomes of individuals with severe, undiagnosed developmental disorders are enriched in damaging de novo mutations (DNMs) in developmentally important genes. Here we have sequenced the exomes of 4,293 families containing individuals with developmental disorders, and meta-analysed these data with data from another 3,287 individuals with similar disorders. We show that the most important factors influencing the diagnostic yield of DNMs are the sex of the affected individual, the relatedness of their parents, whether close relatives are affected and the parental ages. We identified 94 genes enriched in damaging DNMs, including 14 that previously lacked compelling evidence of involvement in developmental disorders. We have also characterized the phenotypic diversity among these disorders. We estimate that 42% of our cohort carry pathogenic DNMs in coding sequences; approximately half of these DNMs disrupt gene function and the remainder result in altered protein function. We estimate that developmental disorders caused by DNMs have an average prevalence of 1 in 213 to 1 in 448 births, depending on parental age. Given current global demographics, this equates to almost 400,000 children born per year